CHINA MESALAZINE MARKET ANALYSIS

China Mesalazine Market, by Route of Administration (Oral and Rectal), by Application (Ulcerative Colitis, Crohn's Disease, and Inflammatory Bowel Disease), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies)- Size, Share, Outlook, and Opportunity Analysis, 2022 - 2030

Published In : Nov 2022
Code : CMI5371
Pages :102
Formats :
Excel and PDF
Industry : Pharmaceutical

Market News

China Mesalazine Market: Key Developments

Market players are engaged in joint ventures which is expected to drive China mesalazine market growth over the forecast period. For instance, in November 2022, Alembic Pharmaceutical Limited, a pharmaceutical company, announced that it had received approval from the U.S. Food and Drug Administration (U.S. FDA) for the Abbreviated New Drug Application (ANDA) for Mesalazine extended–release capsules of strength 0.375 g.